Indications to primary and revision total elbow arthroplasty, clinical outcomes and implant survival rate depending on underlying pathology are discussed in the literature review. Total elbow arthroplasty (TEA) has become the method of choice for severely comminuted distal humerus fractures, posttraumatic conditions and inflammatory arthropathies. TEA can provide substantial improvement in elbow function and quality of life as seen from the review of the foreign and native Russian literature for the last 10 years. However, the complication rate that requires revision surgery remains rather high, and the reported 10-year survival of elbow implants (83-92 %) is lower than that in total hip and knee replacements. Purpose To identify major indications to primary and revision total elbow arthroplasty and explore mid-and long-term results of the procedures based on the review of the foreign and native Russian literature for the last 10 years.